Browsing Category
Pharma Industry News
4765 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Rising Pharmaceuticals launches Edetate calcium disodium injection, alleviating US shortage
Rising Pharmaceuticals, a key player under the Rising Pharma Holdings Inc. umbrella, has triumphantly announced the approval and…
Zetagen Therapeutics secures $10m to boost cancer treatment innovations
Zetagen Therapeutics, a biopharmaceutical firm specializing in advanced treatments for metastatic cancers, has successfully secured a substantial $9.79…
CAS, Molecule.one to collaborate on advanced synthesis design technologies
In a significant development in the realm of drug discovery, CAS, a subsidiary of the American Chemical Society,…
Novo Nordisk to acquire Canadian pharma company Inversago Pharma
Danish pharma major Novo Nordisk A/S has confirmed its plan to acquire Montreal-based Inversago Pharma. The potential cash…
Eli Lilly completes $2.4bn acquisition of DICE Therapeutics
Eli Lilly and Company (Lilly) has finalized its acquisition of DICE Therapeutics, Inc. (NASDAQ: DICE) for $2.4 billion,…
Eli Lilly Q2 2023 financial results highlight robust 28% revenue growth
Eli Lilly and Company (NYSE: LLY) unveiled their Q2 2023 financials, showcasing a 28% revenue enhancement, predominantly driven…
Lupin subsidiary gets FDA approval for Fluocinolone Acetonide Oil
Lupin Limited said that their wholly-owned US subsidiary, Novel Laboratories Inc., has secured approval from the US Food…
Torrent Pharmaceuticals Q1 FY24 snapshot: 10% surge in revenue amid resilient Germany performance
Torrent Pharmaceuticals, a key player in the pharmaceutical landscape, has publicized its financial figures for Q1 FY24, showcasing…
Solara Pharma’s manufacturing site garners positive FDA review
Solara Active Pharma Sciences Ltd’s (Solara Pharma) manufacturing facility in Cuddalore has garnered approval from the US Food…
LIBRETTO-431 study: Lilly’s Retevmo emerges as potential first-line treatment for RET fusion-positive NSCLC
Eli Lilly and Company (NYSE: LLY) has unveiled top-line results from the LIBRETTO-431 study, which focused on the…